EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

Marc Ferrante  1     Alessandra Oortwijn  2     Chohee Yun  3     Jie Zhang  3     Laurent Peyrin-Biroulet  4     Severine Vermeire  5     Silvio Danese     Brian Feagan    
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven,Leuven,Belgium
2 Galapagos NV,Leiden,Netherlands
3 Gilead Sciences Inc.,Foster City, CA,United States
4 Inflammatory Bowel Disease Unit, Nancy University Hospital,Nancy,France
5 Department of Gastroenterology and

Session
IBD: Clinical trials II (small molecules)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing